Switzerland’s Sleep Crisis: €15 Billion Annual Cost – Europe’s Highest

by Dr Natalie Singh - Health Editor
0 comments

Sleep Disorders Costing Switzerland Billions Annually

The economic burden of sleep disorders in Switzerland is substantial, reaching approximately 15 billion francs annually, according to a recent European study. This figure represents the highest per capita cost in Europe, highlighting a growing public health concern.

Rising Prevalence of Sleep Disorders

An estimated 1.7 million people in Switzerland suffer from chronic sleep disorders. Data from the Swiss Health Survey indicates that a third of the population experienced sleep disorders in 2022, a five percentage point increase since 1997. This rise is particularly noticeable among women and young adults aged 15 to 39. Swiss Health Survey 1997—2022

Economic Impact Breakdown

The study, titled “Epidemiology and Economic Burden of Sleep Disorders in Europe,” details the significant financial strain these conditions place on the Swiss healthcare system, and economy. The breakdown of costs includes:

  • Obstructive Sleep Apnea (OSA): 8.6 billion francs
  • Insomnia: 4.2 billion francs
  • Restless Legs Syndrome (RLS): 2.3 billion francs

The total cost per capita is approximately 1,696 francs, significantly higher than the European average of 567 euros. RTS.ch

Health Consequences of Untreated Sleep Disorders

Chronic sleep disorders are linked to a range of serious health issues, including cardiovascular diseases, diabetes, dementia, and depression. These conditions contribute significantly to overall healthcare costs, accounting for approximately 80% of total health expenditures. Réseau Sommeil Suisse

The Broader European Context

A wider European study examining five major sleep disorders – insomnia, obstructive sleep apnea (OSA), narcolepsy, restless legs syndrome (RLS), and REM sleep behavior disorder (RBD) – revealed substantial economic burdens across the continent. OSA and insomnia were the most costly, accounting for €184 billion and €158 billion respectively. PubMed

Estimated prevalence rates across Europe include:

  • OSA: 18%
  • Insomnia: 10%
  • RLS: 3%
  • Narcolepsy: 0.03%
  • RBD: 0.009%

Call for Increased Awareness and Action

Réseau Sommeil Suisse is advocating for greater public awareness regarding the importance of sleep health and the consequences of untreated sleep disorders. They emphasize the need for early identification, improved coordination between prevention, diagnosis, and treatment, and a more comprehensive approach to addressing this growing public health challenge. Réseau Sommeil Suisse

Related Posts

Leave a Comment